Want to create an interactive transcript for this episode?
Podcast: The MSing Link
Episode: 227. Walking Better with MS: The Truth About Ampyra (Dalfampridine) from a Physical Therapist
Description: In this episode, I delve into the intricacies of Ampyra, an FDA-approved medication designed to enhance walking in individuals with multiple sclerosis (MS). Sharing insights from both research and my experience as a physical therapist specializing in MS, I discuss the medication’s impact on walking speed and quality.Â
Discover the importance of maintaining a strict 12-hour medication schedule and learn how Ampyra acts as a potassium channel blocker to enhance nerve conduction. I also provide real-life anecdotes from my MS clients, highlighting improvements in walking quality, reduced spasticity, and fatigue.Â
Join me in exploring how...